Letters To The Editor
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 7, 2014; 20(33): 11927-11928
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11927
Pregnant inflammatory bowel disease patients may require counselling regarding live vaccines in newborns
Adith Sekaran, Marie L Borum
Adith Sekaran, Marie L Borum, Division of Gastroenterology and Liver Diseases, George Washington University Medical Center, Washington DC, NW 20037, United States
Author contributions: Borum ML conducted background research, proposed study, conducted research, analyzed data, contributed to manuscript; Sekaran A conducted background research, contributed to manuscript.
Correspondence to: Marie L Borum, Director, Division of Gastroenterology and Liver Diseases, George Washington University Medical Center, 2121 Eye Street, Washington DC, NW 20037, United States. mborum@mfa.gwu.edu
Telephone: +1-202-7412160 Fax: +1-202-7412169
Received: October 29, 2013
Revised: April 15, 2014
Accepted: June 26, 2014
Published online: September 7, 2014
Core Tip

Core tip: International travel increases potential exposure to a variety of infectious agents. Administration of live vaccines may be important when traveling to certain areas. However, live vaccines pose risks for individuals who are immunosuppressed. This letter addresses the importance of counselling pregnant women with inflammatory bowel disease who are pharmacologically immunosuppressed about live vaccines and potential impact upon the newborn.